METHYLDOPA Drug Patent Profile
✉ Email this page to a colleague
When do Methyldopa patents expire, and what generic alternatives are available?
Methyldopa is a drug marketed by Accord Hlthcare, Chartwell Rx, Duramed Pharms Barr, Halsey, Heritage Pharma, Parke Davis, Pliva, Purepac Pharm, Rising, Roxane, Strides Pharma, Sun Pharm Industries, Superpharm, Teva, Watson Labs, Par Pharm, Dava Pharms Inc, Ivax Sub Teva Pharms, Sandoz, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hospira, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral. and is included in ninety-nine NDAs.
The generic ingredient in METHYLDOPA is methyldopate hydrochloride. There are three drug master file entries for this compound. Additional details are available on the methyldopate hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHYLDOPA?
- What are the global sales for METHYLDOPA?
- What is Average Wholesale Price for METHYLDOPA?
Summary for METHYLDOPA
| US Patents: | 0 |
| Applicants: | 26 |
| NDAs: | 99 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| Clinical Trials: | 19 |
| Patent Applications: | 4,289 |
| Drug Prices: | Drug price information for METHYLDOPA |
| What excipients (inactive ingredients) are in METHYLDOPA? | METHYLDOPA excipients list |
| DailyMed Link: | METHYLDOPA at DailyMed |
Recent Clinical Trials for METHYLDOPA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cairo University | Phase 4 |
| Federal University of Paraíba | Phase 4 |
| Assiut University | Phase 2 |
Pharmacology for METHYLDOPA
| Drug Class | Central alpha-2 Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha2-Agonists |
Medical Subject Heading (MeSH) Categories for METHYLDOPA
US Patents and Regulatory Information for METHYLDOPA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | METHYLDOPA AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; methyldopa | TABLET;ORAL | 070830-001 | Mar 9, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Smith And Nephew | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 070841-001 | Jan 2, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | METHYLDOPA | methyldopa | TABLET;ORAL | 070246-001 | Feb 25, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Industries | METHYLDOPA | methyldopa | TABLET;ORAL | 070060-001 | Oct 9, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | METHYLDOPA AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; methyldopa | TABLET;ORAL | 071921-001 | Aug 29, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
